
Ryan Dinwiddie
Ask VT AI
View News Summary
- Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
- Trump boasts about passing a dementia test, mocking Democrats, but experts say the test is not proof of superior intelligence.
- Drake Maye emerges as a legitimate MVP contender with his impressive performance for the New England Patriots.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
- Trump boasts about passing a dementia test, mocking Democrats, but experts say the test is not proof of superior intelligence.
- Drake Maye emerges as a legitimate MVP contender with his impressive performance for the New England Patriots.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Ryan Dinwiddie
News from Ryan Dinwiddie
